Identification of TWIST-interacting genes in prostate cancer

Peng Lyu, Shu-Dong Zhang, Hiu-Fung Yuen, Cian M McCrudden, Qing Wen, Kwok-Wah Chan, Hang Fai Kwok

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)


Prostate cancer is one of the most common cancers in men worldwide, and the number of diagnosed patients has dramatically increased in recent years. Currently, the clinical parameters used to diagnose prostate cancer, such as Gleason score, pathological tumor staging, and prostate-specific antigen (PSA) expression level, are considered insufficient to inform recommendation to guide clinical practice. Thus, identification of a novel biomarker is necessary. TWIST is one of the well-studied targets and is correlated with cancer invasion and metastasis in several human cancers. We have investigated two largest prostate cancer patient cohorts available in GEO database and found that TWIST expression is positive correlated with Gleason score and associated with poorer survival. By using a prostate cancer cohort and a prostate cancer cell line dataset, we have identified three potential downstream targets of TWIST, PPM1A, SRP72 and TBCB. TWIST's prognostic capacity is lost when the gene is mutated. Further investigation in the prostate cancer cohort revealed that gene expression of SERPINA, STX7, PDIA2, FMP5, GP1BB, VGLL4, KCNMA1, SHMT2, SAA4 and DIDO1 influence the prognostic significance of TWIST and vice versa. Importantly, eight out of these ten genes are prognostic indicator by itself. In conclusion, our study has further confirmed that TWIST is a prognostic marker in prostate cancer, identified its potential downstream targets and genes that could possibly give additional prognostic value to predict TWIST-mediated prostate cancer progression.

Original languageEnglish
Pages (from-to)386-396
JournalScience China. Life sciences
Issue number4
Early online date22 Jan 2017
Publication statusPublished - Apr 2017


  • Journal Article


Dive into the research topics of 'Identification of TWIST-interacting genes in prostate cancer'. Together they form a unique fingerprint.

Cite this